What work are you leading as Managing Director, Global Capital Markets at Morgan Stanley? My focus is meeting biotech companies early and following them through their life cycle as their funding needs ...
Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to next-generation therapeutic platforms. Five biotechs stand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results